{"title":"大剂量卡格列净治疗2型糖尿病的安全性:一项Meta分析","authors":"Chen Qiying, H. Dandan, Chen Tianyu","doi":"10.19803/J.1672-8629.2021.02.11","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10291,"journal":{"name":"中国药物警戒","volume":"24 1","pages":"150"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety of High-dose Canagliflozin for Type 2 Diabetes Mellitus: A Meta Analysis\",\"authors\":\"Chen Qiying, H. Dandan, Chen Tianyu\",\"doi\":\"10.19803/J.1672-8629.2021.02.11\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10291,\"journal\":{\"name\":\"中国药物警戒\",\"volume\":\"24 1\",\"pages\":\"150\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国药物警戒\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.19803/J.1672-8629.2021.02.11\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国药物警戒","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.19803/J.1672-8629.2021.02.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}